Treprostinil Drug Interactions

Brand names
  • Orenitram
  • Tyvaso
  • Remodulin
  • Yutrepia
  • Tyvaso DPI
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated Details about this page

About Treprostinil

Treprostinil is used to treat certain kinds of pulmonary arterial hypertension (PAH; high blood pressure in the vessels carrying blood to the lungs, causing shortness of breath, dizziness, and tiredness). Treprostinil may improve the ability to exercise and slow the worsening of symptoms in patients with PAH.

Read the full Treprostinil drug information page 

The Bottom Line on Treprostinil

Treprostinil helps relax and widen the blood vessels that carry blood to your lungs, which can ease the breathlessness and tiredness of pulmonary arterial hypertension and may slow how fast symptoms worsen.

There is a lot to keep track of here. It has more documented interactions than most medicines, and most of them are rated serious. Bleeding is the problem that comes up most, and it shows up with ibuprofen, sertraline, and trazodone, all of which are rated major.

Supplements, herbs and foods are part of the picture too, with roughly three hundred rated interactions, though only a handful of those are rated major. Whenever something new is on the table, whether it comes from a dentist, an urgent care clinic, or any other prescriber, tell them you take Treprostinil before anything is started.

From the HelloPharmacist Editorial Team Written with AI from this page's interaction records · How we build these pages · How we use AI · Our editorial policy

Check Treprostinil Against Another Drug or Supplement

Type a drug, a brand name or a supplement. We check it against every documented treprostinil interaction, supplements and herbs included.

    What Could Happen When Treprostinil Interacts

    What the 201 documented treprostinil interaction records say could happen, grouped by the problem each one names. Tap a bar to see those drugs.

    This chart covers drug interactions only. Interactions with supplements and herbs are studied far less, so they are not counted here; they have their own section below.

    Treprostinil Interactions by Severity

    Major

    Treprostinil With Supplements and Herbs

    Supplements can interact with treprostinil too. The Natural Medicines database, which we license, rates 293 of them for an interaction with treprostinil, and every one of the 1,330 supplements and herbs we cover has a page on taking it with treprostinil.

    Rated for an Interaction With Treprostinil

    Every Supplement and Herb With Treprostinil, A to Z1,330 pages

    Each one opens its page on taking it with treprostinil, whether or not an interaction is rated.

    Browse every supplement and herb 

    Check a supplement bottle against treprostinil with our drug–supplement interaction checker, or scan its label.

    How Drug Interactions Work New to drug interactions? Six short figures, about a minute, show what can happen when Treprostinil meets another medicine: a level that rises or falls, or effects that add up. See how it works 

    Look Up Another Drug

    Still Have Questions About Treprostinil?

    Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

    About This Library

    Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

    What Each Rating Means

    Severity Levels

    • Contraindicated These should generally not be used together.
    • Major Potentially serious — often needs a change or close monitoring.
    • Moderate Can be significant — usually manageable with monitoring.
    • Minor Usually limited clinical impact.
    Back to the answer

    The References Behind Treprostinil’s Interactions

    The 238 sources our treprostinil interaction records cite: clinical studies, case reports and FDA prescribing information. Each pair's page lists the ones it rests on, numbered in its text, and a source link is one we checked against PubMed or Crossref. How we check them →

    1. Product Information: YUTREPIA(TM) inhalation powder, treprostinil inhalation powder. Liquidia Technologies, Inc (per Manufacturer), Morrisville, NC, 2025. DailyMed 
    2. Product Information: TYVASO DPI® inhalation powder, treprostinil inhalation powder. United Therapeutics Corp, Research Triangle Park, NC, 2025. DailyMed 
    3. Product Information: Tyvaso(R) oral inhalation solution, treprostinil oral inhalation solution. United Therapeutics Corp. (per FDA), Research Triangle Park, NC, 2021. DailyMed 
    4. Product Information: REMODULIN(R) subcutaneous injection, intravenous injection, treprostinil subcutaneous injection, intravenous injection. United Therapeutics Corp. (per Manufacturer), Research Triangle Park, NC, 2014. DailyMed 
    5. Parikh KS, Rajagopal S, Fortin T, et al: Safety and tolerability of high-dose inhaled treprostinil in pulmonary hypertension. J Cardiovasc Pharmacol 2016; 67(4):322-325. PubMed 
    6. Shapiro S, Mandras S, Restrepo-Jaramillo R, et al: Survival and drug persistence in patients receiving inhaled treprostinil at doses greater than 54 µg (nine breaths) four times daily. Pulm Circ 2021; 11(4):1-7. DOI 
    7. Product Information: Tyvaso(R) oral inhalation solution, treprostinil oral inhalation solution. United Therapeutics Corp. (per manufacturer), Research Triangle Park, NC, 2016. DailyMed 
    8. McLaughlin VV, Benza RL, Rubin LJ, et al: Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial. J Am Coll Cardiol 2010; 55(18):1915-1922. PubMed 
    9. Benza RL, Seeger W, McLaughlin VV, et al: Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extension. J Heart Lung Transplant 2011; 30(12):1327-1333. DOI 
    10. Barst RJ, Galie N, Naeije R, et al: Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil. Eur Respir J 2006; 28(6):1195-1203. PubMed 

    Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.